What Will Happen to Concordia International Corp Next? The Stock Just Reaches 52-Week Low


The stock of Concordia International Corp (TSE:CXR) hit a new 52-week low and has $7.73 target or 13.00% below today’s $8.88 share price. The 5 months bearish chart indicates high risk for the $441.70 million company. The 1-year low was reported on Sep, 13 by Barchart.com. If the $7.73 price target is reached, the company will be worth $57.42 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 579,978 shares traded hands. Concordia International Corp (TSE:CXR) has declined 77.40% since February 5, 2016 and is downtrending. It has underperformed by 93.89% the S&P500.

Out of 3 analysts covering Concordia Healthcare Corp (TSE:CXR), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. $105 is the highest target while $34 is the lowest. The $36.33 average target is 309.12% above today’s ($8.88) stock price. Concordia Healthcare Corp has been the topic of 12 analyst reports since September 28, 2015 according to StockzIntelligence Inc.

Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada pharmaceutical company. The company has a market cap of $441.70 million. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply